Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-18-010684

10% owner sold 101,994 shares at an average $50.68 ($5,168,901)

  • 10% owner disposed of 592,918 shares (other)
  • 10% owner acquired 92,918 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Versant Venture Capital IV, L.P. 10% owner 2018-04-20 Other disposition −497,053 2,238,979 I
Versant Venture Capital IV, L.P. 10% owner 2018-04-20 Other disposition −2,947 13,277 I
Versant Venture Capital IV, L.P. 10% owner 2018-04-20 Other acquisition +92,918 92,918 I
Versant Venture Capital IV, L.P. 10% owner 2018-04-20 Other disposition −92,918 0 I
Versant Venture Capital IV, L.P. 10% owner 2018-04-23 Sale −89,628 $50.66 $4,540,554 1,539,576 I
Versant Venture Capital IV, L.P. 10% owner 2018-04-23 Sale −2,630 $51.00 $134,130 45,171 I
Versant Venture Capital IV, L.P. 10% owner 2018-04-23 Sale −2,915 $51.00 $148,665 50,072 I
Versant Venture Capital IV, L.P. 10% owner 2018-04-23 Sale −6,821 $50.66 $345,552 117,173 I
Open-market sales · 101,994 sh · avg $50.68 · $5,168,901
Loading xslF345X03/doc4.xml…